BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 14513045)

  • 1. Vascular endothelial growth factor and its receptors in multiple myeloma.
    Ria R; Roccaro AM; Merchionne F; Vacca A; Dammacco F; Ribatti D
    Leukemia; 2003 Oct; 17(10):1961-6. PubMed ID: 14513045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vascular endothelial growth factor receptor--structure and function].
    Liu L; Hu BC; Zhang YJ
    Sheng Li Ke Xue Jin Zhan; 2000 Jul; 31(3):269-72. PubMed ID: 12545721
    [No Abstract]   [Full Text] [Related]  

  • 3. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
    Zachary I
    IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow angiogenesis in multiple myeloma: closing in on the loop.
    Molina JR; Rajkumar SV
    Haematologica; 2003 Feb; 88(2):122-4. PubMed ID: 12604399
    [No Abstract]   [Full Text] [Related]  

  • 5. The molecular perspective: VEGF and angiogenesis.
    Goodsell DS
    Stem Cells; 2003; 21(1):118-9. PubMed ID: 12529559
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression of VEGF and its receptors by myeloma cells.
    Kumar S; Witzig TE; Timm M; Haug J; Wellik L; Fonseca R; Greipp PR; Rajkumar SV
    Leukemia; 2003 Oct; 17(10):2025-31. PubMed ID: 14513053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulators of angiogenesis as targets for anti-angiogenic tumor therapy.
    Breier G; Heidenreich R; Gaumann A; Groot M; Licht A; Nicolaus A; Schmitz J; Reichmann E; Plate KH; Vajkoczy P
    Ann Hematol; 2002; 81 Suppl 2():S71-2. PubMed ID: 12611084
    [No Abstract]   [Full Text] [Related]  

  • 8. A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma.
    Vacca A; Ria R; Ribatti D; Semeraro F; Djonov V; Di Raimondo F; Dammacco F
    Haematologica; 2003 Feb; 88(2):176-85. PubMed ID: 12604407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
    Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
    Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor.
    Sengupta S; Gherardi E; Sellers LA; Wood JM; Sasisekharan R; Fan TP
    Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):69-75. PubMed ID: 12524227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biology of VEGF and its receptors.
    Ferrara N; Gerber HP; LeCouter J
    Nat Med; 2003 Jun; 9(6):669-76. PubMed ID: 12778165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis in multiple myeloma.
    Sezer O; Niemöller K; Jakob C; Heider U
    Leuk Res; 2002 Jul; 26(7):701-2. PubMed ID: 12008091
    [No Abstract]   [Full Text] [Related]  

  • 13. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
    Ferrara N
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway].
    Wang F; Tian YH; Li L; Chen XF; Hu HH; Li CY; Huang Q
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):165-70. PubMed ID: 12006990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vascular endothelial growth factor--fundamental research and experimental study in plastic surgery].
    Huang CY; Shen ZY
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Jan; 16(1):64-9. PubMed ID: 11826659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF and the quest for tumour angiogenesis factors.
    Ferrara N
    Nat Rev Cancer; 2002 Oct; 2(10):795-803. PubMed ID: 12360282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms and role of lymphangiogenesis in cancer metastasis].
    Dupuy E; Tobelem G
    Bull Cancer; 2003 Jul; 90(7):595-9. PubMed ID: 12957800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Angiogenesis--vascular endothelial growth factor and its receptors].
    Shibuya M
    Hum Cell; 1999 Mar; 12(1):17-24. PubMed ID: 10457901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanisms of vasculogenesis and angiogenesis. What regulates vascular growth?].
    Joussen AM; Kirchhof B; Gottstein C
    Ophthalmologe; 2003 Apr; 100(4):284-91. PubMed ID: 12682760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.